Abstract
A major constituent of the amyloid fibrils in dialysis-related amyloidosis is β2-microglobulin (β2-MG). Heparan sulphates (HS) co-localize with the amyloid fibrils and monocytes/macrophages are commonly found around amyloid deposits, but the role of HS in amyloidogenesis is not yet defined. HS have variable saccharide sequences and can interact specifically with basic fibroblast growth factor (bFGF), a potent chemotactic factor for the monocyte/macrophage. The present investigation was undertaken to look for a functional link between co-localized HS and the pathogenesis of dialysis-related amyloidosis. Using amyloid-enriched ligament, immunohistochemical localization was tested for β2-MG, endogenous bFGF, and bFGF-binding portions of HS. For the detection of bFGF-binding portions of HS, the ligament sections were incubated with exogenous bFGF and then with anti-bFGF antibody. The specificity of the interaction between bFGF and HS was established by confirming a concomitant loss of immunoreactivity during selective removal of HS with heparitinase. β2-MG, endogenous bFGF, and bFGF-binding portions of HS were detected between bundles of collagen. Endogenous bFGF and bFGF-binding portions of HS were not detected in more advanced amyloid lesions, whereas β2-MG and other portions of HS were detected. We propose that β2-MG, endogenous bFGF, and bFGF-binding portions of HS form a complex and localize in the early amyloid lesions of dialysis-related amyloidosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Gejyo F, Yamada T, Odani S, Nakagawa P, Arakawa M, Kunimoto T, Kitaoka H, Suzuki M, Hirosawa Y, Shirahama T, Cohen AS, Schmid K (1985) A new form of amyloid protein associated with chronic hemodialysis was identified as β2-microglobulin. Biochem Biophys Res Commun 129:701–706
Shirahama T, Skinner M, Cohen AS, Gejyo F, Arakawa M, Suzuki M, Hirasawa Y (1985) Histochemical and immunohistochemical characterization of amyloid associated with chronic hemodialysis as β2-microglobulin. Lab Invest 53:705–709
Linke RP, Bommer J, Ritz E, Waldherr R, Eulitz M (1986) Amyloid kidney stones of uremic patients consist of β2-microglobulin fragments. Biochem Biophys Res Commun 136:665–671
Linke RP, Hampl H, Bartel-Schwarze S, Eulitz M (1987) Beta-2microglobulin different fragments and polymers thereof in synovial amyloid in long-term hemodialysis. Biol Chem 368:137–144
Odani H, Oyama R, Titani K, Ogawa H, Saito A (1990) Purification and complete amino acid sequence of novel β2-microglobulin. Biochem Biophys Res Commun 168:1223–1229
Miyata T, Oda O, Inagi R, Iida Y, Araki N, Yamada N, Horiuchi S, Taniguchi N, Maeda K, Kinoshita T (1993) β2-microglobulin modified with advanced glycation end products is a major component of hemodialysis-associated amyloidosis. J Clin Invest 92:1243–1252
Kjellen L, Lindahl U (1991) Proteoglycans: structures and interactions. Annu Rev Biochem 60:443–475
Klagsbrum M (1992) Mediators of angiogenesis: the biological significance of basic fibroblast growth factor (bFGF)-heparin and heparan sulfate interactions. Semin Cancer Biol 3:81–87
Habuchi H, Suzuki S, Saito T, Tamura T, Harada T, Yoshida K, Kimata K (1992) Structure of heparan sulphate oligosaccharide that binds to basic fibroblast growth factor. Biochem J 285:805–813
Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58:575–606
Gospodarowicz D (1991) Biological activities of fibroblast growth factors. The fibroblast growth factor family. Ann N Y Acad Sci 638:1–8
Rifkin DB, Moscatelli D (1989) Recent developments in the cell biology of basic fibroblast growth factor. J Cell Biol 109:1–6
Baird A, Walicke PA (1989) Fibroblast growth factors. Br Med Bull 45:438–452
Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn C-M, Waksman G (1995) FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 268:432–436
Puchtler H, Sweat F, Levine M (1962) On the binding of congo red by amyloid. J Histochem Cytochem 10:355–364
Matsuzaki K, Yoshitake Y, Matuo Y, Sasaki H, Nishikawa K (1989) Monoclonal antibodies against heparin-binding growth factor II/ basic fibroblast growth factor that block its biological activity: invalidity of the antibodies for tumor angiogenesis. Proc Natl Acad Sci USA 86:9911–9915
Morita H, Shinzato T, David G, Mizutani A, Habuchi H, Fujita Y, Ito M, Asai J, Maeda K, Kimata K (1994) Basic fibroblast growth factor-binding domain of heparan sulfate in the human glomerulosclerosis and renal tubulointerstitial fibrosis. Lab Invest 71:528–535
Suzuki S, Mizutani A, Koike Y, Kato M, Yoshida K, Kimata K (1991) Glycosaminoglycan chains of proteoglycans: approaches to the study of their structure and function. Pure Appl Chem 63:545–554
David G, Mei Bai X, Van derSchueren B, Cassiman JJ, Van DenBerghe H (1992) Developmental changes in heparan sulfate expression: in situ detection with mAbs. J Cell Biol 119:961–975
Kato M, Koike Y, Suzuki S, Kimata K (1988) Basement membrane proteoglycan in various tissues: characterization using monoclonal antibodies to the Engelbreth-Holm-Swarm mouse tumor low density heparan sulfate proteoglycan. J Cell Biol 106:2203–2210
DeBoeck H, Lories V, David G, Cassiman JJ, Van denBerghe H (1987) Identification of a 64 kDa heparan sulphate proteoglycan core protein from human lung fibroblast plasma membranes with a monoclonal antibody. Biochem J 247:765–771
Aruga E, Ozasa H, Teraoka S, Ota K (1993) Macromolecules that are colocalized with deposits of β2-microglobulin in hemodialysis- associated amyloidosis. Lab Invest 69:223–230
Kisilevsky R (1990) Heparan sulfate proteoglycans in amyloidogenesis: an epiphenomenon, a unique factor, or the tip of a more fundamental process? Lab Invest 63:589–591
Ohishi H, Skinner M, Sato-Araki N, Okuyama T, Gejyo F, Kimura A, Cohen AS, Schmid K (1990) Glycosaminoglycans of the hemodialysis-associated carpal synovial amyloid and of amyloid-rich tissues and fibrils of heart, liver, and spleen. Clin Chem 36:88–91
Gejyo F, Maruyama H, Teramura T, Kazama J, Ei I, Arakawa M (1995) Role of macrophages in β2-microglobulin-related dialysis amyloidosis. Contrib Nephrol 112:97–104
Miyata T, Inagi R, Iida Y, Sato M, Yamada N, Oda O, Maeda K, Seo H (1994) Involvement of β2-microglobulin modified with advanced glycation end products in the pathogenesis of hemodialysis-associated amyloidosis: induction of human monocyte chemotaxis and macrophage secretion of tumor necrosis factor-α and interleukin-1. J Clin Invest 93:521–528
Iida Y, Miyata T, Inagi R, Sugiyama S, Maeda K (1994) β2-Microglobulin modified with advanced glycation end products induces interleukin-6 from human macrophages: role in the pathogenesis of hemodialysis-associated amyloidosis. Biochem Biophys Res Commun 210:1235–1241
Alizadeh-Khiavi K, Ali-Khan Z (1988) Biochemical nature and cellular origin of amyloid enhancing factor (AEF) as determined by anti-AEF antibody. Br J Exp Pathol 69:605–619
Ogawa H, Ono M, Hisanaga S, Saito A, Momoi T, Takagi T, Ishiguro N, Titani K, Suzuki M (1995) Biochemical and histopathological study of β2-microglobulin amyloidosis. Contrib Nephrol 112:105–110
Gejyo F, Maruyama H, Arakawa M (1995) Amyloidosis associated with long-term dialysis. Jpn J Nephrol 37:1–6
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morita, H., Shinzato, T., Cai, Z. et al. Basic fibroblast growth factor-heparan sulphate complex in the human dialysis-related amyloidosis. Vichows Archiv A Pathol Anat 427, 395–400 (1995). https://doi.org/10.1007/BF00199388
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00199388